BRIEF-Xoma Acquires Royalty Interest Position In Six Clinical-Stage Assets [Reuters]
XOMA Corporation (XOMA)
Last xoma corporation earnings: 3/10 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.xoma.com/investor-relations
Company Research
Source: Reuters
BRIEF-Xoma Acquires Royalty Interest Position In Six Clinical-Stage Assets - Reuters 1 Min Read Sept 26 (Reuters) - XOMA Corp: * XOMA ACQUIRES ROYALTY INTEREST POSITION IN SIX CLINICAL-STAGE ASSETS * XOMA CORP - ACQUIRED A ROYALTY INTEREST IN SIX CLINICAL-STAGE ASSETS TARGETING ADENOSINE PATHWAY FOR $10.0 MILLION FROM PALOBIOFARMA S.L. * XOMA CORP - WILL RECEIVE LOW SINGLE-DIGIT ROYALTIES ON FUTURE SALES OF THESE SIX ADENOSINE RECEPTOR ASSETS * XOMA - CO HAS ACQUIRED A ROYALTY INTEREST IN NIR178, THAT IS BEING DEVELOPED BY NOVARTIS AS A NOVEL CHECKPOINT INHIBITOR FOR TREATMENT OF SOLID TUMORS Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2019 Reuters. All Rights Reserved. BRIEF-Xoma Acquires Royalty Interest Position In Six Clinical-Stage Assets Sept 26 (Reuters) - XOMA Corp: * XOMA ACQUIRES ROYALTY INTEREST POSITION IN SIX CLINICAL-STAGE ASSETS * XOMA CORP - ACQUIRED A ROY
Show less
Read more
Impact Snapshot
Event Time:
XOMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XOMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XOMA alerts
High impacting XOMA Corporation news events
Weekly update
A roundup of the hottest topics
XOMA
News
- XOMA Corporation Announces Closing of Tender Offer [Yahoo! Finance]Yahoo! Finance
- XOMA Corporation Announces Closing of Tender OfferGlobeNewswire
- XOMA Declares Quarterly Preferred Stock DividendsGlobeNewswire
- XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc. [Yahoo! Finance]Yahoo! Finance
- XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.GlobeNewswire
XOMA
Earnings
- 11/7/23 - Miss
XOMA
Analyst Actions
- 2/16/24 - HC Wainwright
XOMA
Sec Filings
- 4/3/24 - Form 8-K
- 4/2/24 - Form ARS
- 4/2/24 - Form DEFA14A
- XOMA's page on the SEC website